Alexandra B. Maulden

Substance Use Disorder Treatment Services: 2025 Physician Fee Schedule Proposed Rule Would Expand Access And Medicare Coverage

Clinical Trials: FDA Publishes Draft Guidance On Diversity Action Plans

2024 Health Care & Life Sciences Top Trends - Driving Tomorrow's Advances In The Health Care And Life Sciences Ecosystems

New Favorable OIG Advisory Opinion Allows Patient Assistant Programs Funded By Drug Manufacturers

Opioid Treatment Programs: SAMHSA Makes Permanent Regulatory Flexibilities

Behavioral Health: CMS Innovation Model Outlines Changes For The Delivery Of Integrated Behavioral And Physical Health Care

CMS Expands Access To Behavioral Health Services; Physician Fee Schedule Expands Billing Providers And Flexibilities

FDA: New Draft Guidance On Communication Of Unapproved Uses Of Approved Or Cleared Medical Products

FDA's New Enforcement Policy: A Win For Remote Patient Monitoring And Remote Therapeutic Monitoring Manufacturers

FDA Issues New Warning Regarding Compounded Ketamine